Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$373M |
| 2 |
Costco
COST
|
+$283M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$270M |
| 4 |
Pfizer
PFE
|
+$240M |
| 5 |
Microsoft
MSFT
|
+$225M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$274M |
| 2 |
EMC
EMC CORPORATION
EMC
|
+$228M |
| 3 |
GAS
AGL Resources Inc
GAS
|
+$216M |
| 4 |
TE
TECO ENERGY INC
TE
|
+$136M |
| 5 |
Charter Communications
CHTR
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.61% |
| 2 | Healthcare | 12.42% |
| 3 | Financials | 11.99% |
| 4 | Consumer Staples | 9.6% |
| 5 | Industrials | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
ASML
ASML
$596B
| $2.77M | ﹤0.01% |
25,207
-103,078
| -80% | -$10.9M |
|
2002
Escalade
ESCA
$271M
| $2.76M | ﹤0.01% |
216,200
+13,964
| +7% | +$162K |
|
|
SGMO
2003
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $2.75M | ﹤0.01% |
594,500
+480,300
| +421% | +$2.44M |
|
2004
DXP Enterprises
DXPE
$2.3B
| $2.75M | ﹤0.01% |
97,600
-171,800
| -64% | -$3.96M |
|
2005
Energy Transfer Partners
ET
$69.5B
| $2.74M | ﹤0.01% |
163,352
-1,545,200
| -90% | -$26.1M |
|
2006
Pampa Energía
PAM
$4.57B
| $2.73M | ﹤0.01% |
84,400
-118,800
| -58% | -$3.31M |
|
2007
Tandem Diabetes Care
TNDM
$1.27B
| $2.73M | ﹤0.01% |
35,640
+6,210
| +21% | +$453K |
|
|
LBAI
2008
DELISTED
Lakeland Bancorp Inc
LBAI
| $2.72M | ﹤0.01% |
193,700
-62,402
| -24% | -$798K |
|
|
MBVT
2009
DELISTED
Merchants Bancshares Inc
MBVT
| $2.72M | ﹤0.01% |
83,900
+11,200
| +15% | +$362K |
|
|
FPRX
2010
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $2.71M | ﹤0.01% |
51,700
-69,600
| -57% | -$3.32M |
|
|
CVSA
2011
Covista Inc
CVSA
$4.55B
| $2.71M | ﹤0.01% |
117,300
+61,600
| +111% | +$1.38M |
|
2012
Crown Crafts
CRWS
$31.6M
| $2.71M | ﹤0.01% |
265,200
+10,800
| +4% | +$107K |
|
|
RDC
2013
DELISTED
Rowan Companies Plc
RDC
| $2.69M | ﹤0.01% |
177,800
-250,900
| -59% | -$3.67M |
|
|
GRP.U
2014
DELISTED
Granite Real Estate Investment Trust
GRP.U
| $2.69M | ﹤0.01% |
87,900
-53,200
| -38% | -$1.65M |
|
2015
Bankwell Financial Group
BWFG
$543M
| $2.69M | ﹤0.01% |
113,500
+18,100
| +19% | +$409K |
|
2016
RB Global
RBA
$21.5B
| $2.69M | ﹤0.01% |
+76,600
| New | +$2.5M |
|
2017
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$7.05B
| $2.67M | ﹤0.01% |
24,267
+16,300
| +205% | +$1.77M |
|
|
CXDC
2018
DELISTED
China XD Plastics Company Limited
CXDC
| $2.67M | ﹤0.01% |
604,400
+15,100
| +3% | +$69.7K |
|
|
BSMX
2019
DELISTED
Banco Santander México, S, A., Institución de Banca Múltiple, Grupo Financiero Santander México
BSMX
| $2.67M | ﹤0.01% |
303,400
-588,300
| -66% | -$5.45M |
|
|
BGG
2020
DELISTED
Briggs & Stratton Corp.
BGG
| $2.67M | ﹤0.01% |
+143,000
| New | +$2.95M |
|
|
EXAC
2021
DELISTED
Exactech Inc
EXAC
| $2.67M | ﹤0.01% |
98,600
+8,500
| +9% | +$234K |
|
|
RLH
2022
DELISTED
Red Lions Hotel Corporation
RLH
| $2.65M | ﹤0.01% |
318,300
-34,700
| -10% | -$255K |
|
2023
Arbor Realty Trust
ABR
$977M
| $2.65M | ﹤0.01% |
357,500
+78,741
| +28% | +$583K |
|
2024
Trupanion
TRUP
$1.13B
| $2.65M | ﹤0.01% |
156,800
-25,500
| -14% | -$390K |
|
|
PPBI
2025
DELISTED
Pacific Premier Bancorp
PPBI
| $2.65M | ﹤0.01% |
100,100
-64,800
| -39% | -$1.68M |
|
Similar funds
Renaissance Technologies's Q3 2016 Portfolio in Review
As of Q3 2016, Renaissance Technologies held 3,713 positions worth $56.6B, up 7.7% from $52.5B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Renaissance Technologies deployed $1.92B of net new capital in Q3 2016, opening 414 new positions and adding to 1,834 existing holdings. Its largest new stake was FedEx: 811,400 shares worth $142M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was CVS Health, an estimated $274M trimmed.
- Renaissance Technologies's largest Q3 2016 buy was FedEx: 811,400 shares worth $142M.
- Renaissance Technologies added most to Alphabet (Google) Class A in Q3 2016, an estimated $373M increase.
- Renaissance Technologies's biggest Q3 2016 reduction was CVS Health, cutting an estimated $274M.
- Renaissance Technologies fully exited EMC CORPORATION in Q3 2016, selling an estimated $228M.
- Renaissance Technologies's ten largest holdings make up 7.9% of its $56.6B portfolio in Q3 2016.
- Renaissance Technologies opened 414 new positions and closed 416 in Q3 2016.
- Renaissance Technologies's portfolio value rose 7.7% quarter-over-quarter to $56.6B.
Based on Renaissance Technologies's 13F filing for Q3 2016, filed 14 Nov 2016.